Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.68 |
| ▸ | CA9 | Q16790 | 5/20 | 0.45 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8093078 | 0.91 | PTGS2 (0.83) | PTGS2PTGS1CA9CA1CA2 | |
| SCHEMBL8776828 | 0.91 | PTGS2 (0.67) | PTGS2PTGS1CA9CA1CA2 | |
| SCHEMBL8093872 | 0.91 | PTGS2 (0.83) | PTGS2PTGS1 | |
| SCHEMBL8776857 | 0.91 | PTGS2 (0.70) | PTGS2PTGS1CNR1 | |
| SCHEMBL8094676 | 0.90 | PTGS2 (0.61) | PTGS2PTGS1CA9CA1CA2 | |
| SCHEMBL8095136 | 0.90 | PTGS2 (0.66) | PTGS2PTGS1CA9CA1CA2 | |
| SCHEMBL8095142 | 0.86 | PTGS2 (0.57) | PTGS2PTGS1CA9CA1CA2 | |
| SCHEMBL8093714 | 0.85 | PTGS2 (0.58) | PTGS2PTGS1CA9CA1CA2 | |
| SCHEMBL8094362 | 0.84 | PTGS2 (0.59) | PTGS2PTGS1CA9CA1CA2 | |
| SCHEMBL8093708 | 0.84 | PTGS2 (0.59) | PTGS2PTGS1CA9CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0808304-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-11-26 | — | — | EP | claimed |
| WO-1996024584-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | claimed |
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | disclosed |